Feature Channels: Respiratory Diseases and Disorders

Filters close
Released: 1-Jun-2021 4:20 PM EDT
Signs of COVID-19 Mortality May be Easily Measured at Home
RUSH

Two easily measurable signs of health are distinctly predictive of higher mortality among patients hospitalized with COVID-19, according to a study examining the cases of inpatients with COVID-19 at Rush University Medical Center and University of Washington Medicine hospitals.

Released: 28-May-2021 1:05 PM EDT
Helping doctors manage COVID-19
University of Waterloo

Artificial intelligence (AI) technology developed by researchers at the University of Waterloo is capable of assessing the severity of COVID-19 cases with a promising degree of accuracy.

   
Released: 27-May-2021 11:55 AM EDT
Inflammation and Procalcitonin Predict Success, or Not, of Lung Cancer Treatment
Sbarro Health Research Organization (SHRO)

In patients with non-small cell Lung Cancer (NSCLC), the presence of either high chronic inflammation, or procalcitonin levels in the blood as a response to bacterial infection, both predict a poor response to treatment with immune checkpoint blockade.

Released: 26-May-2021 2:15 PM EDT
Study confirms longer-term lung damage after COVID-19
University of Sheffield

Hyperpolarised xenon MRI detected lung damage which was not picked up by routine CT scans and clinical tests

Released: 26-May-2021 10:40 AM EDT
University Hospitals First in Northeast Ohio to Use New Technology for Lung Cancer Diagnosis
University Hospitals Cleveland Medical Center

A new innovation that holds promise to fight lung cancer is now in use at University Hospitals Cleveland Medical Center.

Released: 19-May-2021 11:15 AM EDT
UB pharmacy researcher aims to develop real-time algorithm to lower hospital readmission rates
University at Buffalo

To lower hospital readmission rates for patients with chronic obstructive pulmonary disease (COPD), University at Buffalo pharmacy researcher David Jacobs has received a $962,000 award from the National Heart, Lung, and Blood Institute to develop a real-time readmission risk prediction algorithm.

10-May-2021 8:30 AM EDT
Two-Fifths of U.S. Seniors with COPD Have Poor Access to Pulmonary Rehabilitation
American Thoracic Society (ATS)

Approximately two-fifths of Medicare beneficiaries with chronic obstructive pulmonary disease (COPD) have limited access to pulmonary rehabilitation services due to their distance from rehab centers, according to research presented at the ATS 2021 International Conference. More than 24 million U.S. adults suffer from COPD, a smoking related disease.

10-May-2021 8:30 AM EDT
Secondhand Tobacco Smoke Exposure in Utero, Early Childhood, Linked to Decreased Lung Function in Children
American Thoracic Society (ATS)

Environmental tobacco smoke exposure in utero and during early childhood—especially secondhand smoke—is associated with decreased childhood lung function, according to research presented at the ATS 2021 International Conference.

Released: 18-May-2021 10:15 AM EDT
Lung disease specialist takes up chair named for mentor
McMaster University

Kolb is research director at the Firestone Institute for Respiratory Health at McMaster and St. Joseph’s Healthcare Hamilton, as well as division director for respirology at the Department of Medicine. He is also the European Respiratory Journal’s chief editor.

10-May-2021 8:30 AM EDT
Lives May Be Saved by Implementing ATS-Recommended Air Quality Standards;
American Thoracic Society (ATS)

Air quality standards recommended by the American Thoracic Society (ATS) have the potential to prevent more illness and death than standards adopted by the U.S. Environmental Protection Agency (EPA), according to research presented at the ATS 2021 International Conference.

Released: 17-May-2021 11:20 AM EDT
Clinical Trials Day: Empowering Patients to Participate in Active Pulmonary Fibrosis Trials
Pulmonary Fibrosis Foundation

To mark Clinical Trials Day on May 20, the Pulmonary Fibrosis Foundation (PFF) aims to herald the positive impact clinical trials have made on the pulmonary fibrosis (PF) community, the current advancements in research and the importance of patient involvement.

Released: 17-May-2021 8:50 AM EDT
Polly E. Parsons, MD, ATSF Named 2021 Edward Livingston Trudeau Medalist
American Thoracic Society (ATS)

The American Thoracic Society has named Polly E. Parsons, MD, ATSF, and past president of the ATS, as the 2021 Edward Livingston Trudeau Medalist. The award was presented during the 2021 ATS International Conference.

10-May-2021 8:30 AM EDT
Removal of “Race Correction” in Pulmonary Function Tests Shows More Prevalent and Severe Lung Disease Among Black Patients
American Thoracic Society (ATS)

By removing “race correction” from the interpretation of pulmonary function test (PFT) results, Black individuals were shown to have a significantly higher prevalence and severity of lung disease, according to research presented at the ATS 2021 International Conference.

10-May-2021 8:30 AM EDT
Poverty is Associated with Worse Survival and Fewer Lung Transplants in Patients with Lung Disease
American Thoracic Society (ATS)

Patients with idiopathic pulmonary fibrosis (IPF), a rare lung disease that causes shortness of breath and low oxygen levels because of lung scarring, have worse outcomes if they live in poor neighborhoods, according to research presented at the ATS 2021 International Conference.

Released: 14-May-2021 1:45 PM EDT
Health outcomes differ between UK and US children with cystic fibrosis
University of Liverpool

A new study led by University of Liverpool researchers has confirmed that children with cystic fibrosis (CF) in the US have better lung function than UK children with the disease.

10-May-2021 8:30 AM EDT
E-Cigarette Use Is Associated with Wheezing and Shortness of Breath, Even for Young Adults Who Don’t Smoke
American Thoracic Society (ATS)

The use of e-cigarettes is associated with wheezing and shortness of breath in young adults and adolescents, even in those who don’t smoke cigarettes or marijuana, according to research presented at the ATS 2021 International Conference.

Released: 13-May-2021 5:30 AM EDT
Novel nanotech improves cystic fibrosis antibiotic by 100,000-fold
University of South Australia

World-first nanotechnology developed by the University of South Australia could change the lives of thousands of people living with cystic fibrosis (CF) as groundbreaking research shows it can improve the effectiveness of the CF antibiotic Tobramycin, increasing its efficacy by up to 100,000-fold.

10-May-2021 10:25 AM EDT
Artificial Intelligence Tool Uses Chest X-ray to Differentiate Worst Cases of COVID-19
NYU Langone Health

Trained to see patterns by analyzing thousands of chest X-rays, a computer program predicted with up to 80 percent accuracy which COVID-19 patients would develop life-threatening complications within four days, a new study finds.

   
Released: 11-May-2021 3:45 PM EDT
This stinks: New research finds sense of smell and pneumonia linked
Michigan State University

An acute loss of smell is one of the most common symptoms of COVID-19, but for two decades it has been linked to other maladies among them Parkinson’s disease and dementia. Now, a poor sense of smell may signify a higher risk of pneumonia in older adults, says a team of Michigan State University researchers.

Released: 11-May-2021 3:15 PM EDT
How to predict severe influenza in hospitalised patients
University of Melbourne

Published today in Nature Communications, the team from the Peter Doherty Institute for Infection and Immunity (Doherty Institute), Alfred Health and Monash University sought to understand which patients would recover quickly from influenza and which would become severely ill.

Released: 11-May-2021 8:05 AM EDT
University Hospitals First in the World to Integrate New General Electric Healthcare Imaging System into Daily Clinical Practice
University Hospitals Cleveland Medical Center

University Hospitals in Cleveland is the global pioneer in full clinical adoption of GE Healthcare’s new Critical Care Suite 2.0, the world’s first on-device artificial intelligence program helping to assess endotracheal tube placement.

Released: 10-May-2021 3:40 PM EDT
HEPA过滤器可减少剧烈运动时产生的空气传播呼吸道微粒
Mayo Clinic

呼吸气溶胶是呼吸气体的常见组成部分,也是COVID-19等呼吸道病毒传播给他人和各种表面的常见途径。在妙佑医疗国际(Mayo Clinic) 对心脏病患者进行运动负荷试验的研究人员发现,随着运动强度的增加,房间周围气溶胶的浓度也会增加。他们还发现,高效微粒空气过滤器(HEPA)可有效地过滤气溶胶,减少患者之间更换清新空气所需的时间。

Released: 10-May-2021 3:30 PM EDT
تقلل منقيات جزيئات الهواء عالية الكفاءة من الجزيئات التنفسية المنقولة بالهواء المتولدة أثناء ممارسة التمارين الشاقة
Mayo Clinic

مدينة روتشستر، ولاية مينيسوتا — رذاذ الأيروسول التنفسي مكون شائع للنفس، وطريقة شائعة لنشر فيروسات الجهاز التنفسي مثل فيروس كورونا المستجد (كوفيد-19) إلى الأشخاص والأسطح الأخرى. وجد الباحثون الذين أجروا اختبارات الإجهاد المتعلقة بالتمارين لمرضى القلب في مايو كلينك أن ممارسة الرياضة بمستويات متزايدة من المجهود تزيد من تركيز الأيروسول في الغرفة المحيطة. ووجدوا أيضًا أن منقيات جزيئات الهواء عالية الكفاءة (HEPA) ترشح رذاذ الأيروسول بشكل فعال وتقلل الوقت اللازم لتنقية الهواء بين المرضى.

Released: 10-May-2021 3:05 PM EDT
TB immune response discovery could significantly reduce disease harm
University College London

A pioneering study by UCL scientists has discovered the presence of a harmful inflammatory protein in patients with symptomatic tuberculosis (TB).

Released: 10-May-2021 2:35 PM EDT
Virtual Lung Cancer Screenings Being Offered by Hackensack Meridian Health
Hackensack Meridian Health

Telehealth Visits Provide Early Detection, More Treatment Options and Better Chance of Survival

Released: 10-May-2021 1:55 PM EDT
O filtro HEPA reduz as partículas respiratórias transportadas pelo ar geradas durante exercícios intensos
Mayo Clinic

Aerossóis respiratórios são um componente comum da respiração e são uma forma comum de vírus respiratórios, como o COVID-19 , se espalharem para outras pessoas e superfícies. Os pesquisadores que realizam testes de esforço físico para pacientes cardíacos na Mayo Clinic descobriram que praticar exercícios em níveis crescentes de esforço aumentava a concentração de aerossol no ambiente ao redor. Eles também descobriram que um filtro de ar particulado de alta eficiência (HEPA) filtrou de forma eficaz os aerossóis e diminuiu o tempo necessário para limpar o ar entre os pacientes.

Released: 10-May-2021 1:05 PM EDT
El filtro HEPA reduce las partículas respiratorias transmitidas por el aire que se generan durante el ejercicio intenso
Mayo Clinic

Los aerosoles respiratorios son un componente común de la respiración y constituyen una vía común de propagación de virus respiratorios como la COVID-19 a personas y superficies. Los investigadores que realizan pruebas de esfuerzo físico en pacientes con problemas cardíacos en Mayo Clinic hallaron que el ejercicio a niveles mayores de esfuerzo aumentaba la concentración de aerosoles en el entorno circundante. Además, descubrieron que el filtro recogedor de partículas de alta eficiencia (HEPA, por sus siglas en inglés) descartaba de manera eficaz los aerosoles y disminuía el tiempo necesario para purificar el aire entre los pacientes.

Released: 10-May-2021 12:50 PM EDT
Scientists develop better way to block viruses that cause childhood respiratory infections
University of Wisconsin–Madison

By engineering a short chunk of protein, or peptide, that can prevent the attachment of human parainfluenza viruses to cells, researchers have improved a method in rodent models intended to help keep children healthy.

Released: 7-May-2021 11:15 AM EDT
Asthma attacks plummeted among Black and hispanic/latinx individuals during the COVID-19 pandemic
Brigham and Women’s Hospital

Asthma attacks account for almost 50 percent of the cost of asthma care which totals $80 billion each year in the United States

Released: 6-May-2021 4:50 PM EDT
Molecular analysis identifies key differences in lungs of cystic fibrosis patients
Cedars-Sinai

A team of researchers from UCLA, Cedars-Sinai and the Cystic Fibrosis Foundation has developed a first-of-its-kind molecular catalog of cells in healthy lungs and the lungs of people with cystic fibrosis.

Released: 6-May-2021 2:15 PM EDT
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
Front Line COVID-19 Critical Care Alliance (FLCCC Alliance)

After the Most Comprehensive Review to Date, a Panel of Leading Medical Experts Conclude that Ivermectin Should be Systematically and Globally Adopted for the Prevention and Treatment of COVID-19

Released: 6-May-2021 11:55 AM EDT
Cystic fibrosis: towards better treatment and stronger lungs
Universite de Montreal

In their lab, CRCHUM scientists Emmanuelle Brochiero and Damien Adam are studying ways of better predicting the efficacy of medications and helping injured lungs repair and regenerate.

4-May-2021 10:05 PM EDT
Molecular Analysis Identifies Key Differences in Lungs of Cystic Fibrosis Patients
University of California, Los Angeles (UCLA), Health Sciences

A team of researchers from UCLA, Cedars-Sinai and the Cystic Fibrosis Foundation has developed a first-of-its-kind molecular catalog of cells in healthy lungs and the lungs of people with cystic fibrosis. The findings could help scientists in their search for specific cell types that represent prime targets for genetic and cell therapies for cystic fibrosis.

Released: 5-May-2021 9:00 AM EDT
A Calculator that Predicts Risk of Lung Cancer Underperforms in Diverse Populations
Thomas Jefferson University

Research finds that a commonly used risk-prediction model for lung cancer does not accurately identify high-risk Black patients who could benefit from early screening.

Released: 5-May-2021 9:00 AM EDT
The Role of Air Pollution in Pulmonary Fibrosis
Pulmonary Fibrosis Foundation

To mark Clean Air Month, the Pulmonary Fibrosis Foundation (PFF) aims to increase public understanding of the role air pollution has in the development of interstitial lung diseases (ILD) such as pulmonary fibrosis (PF), including how polluted air can make you sick and the telltale signs to be aware of.

   
Released: 4-May-2021 1:10 PM EDT
HEPA filter effectively reduces airborne respiratory particles generated during vigorous exercise that can transmit viruses
Mayo Clinic

A pair of Mayo Clinic studies shed light on something that is typically difficult to see with the eye: respiratory aerosols. Such aerosol particles of varying sizes are a common component of breath, and they are a typical mode of transmission for respiratory viruses like COVID-19 to spread to other people and surfaces.

   
Released: 4-May-2021 8:55 AM EDT
First time in Thailand – Chula Successfully Uses Stem-cell Transplantation to Treat Systemic Sclerosis Patients with Pulmonary Fibrosis
Chulalongkorn University

April 8, 2021 – The Division of Rheumatology, Department of Medicine, Faculty of Medicine (CU Medi), Chulalongkorn University and King Chulalongkorn Memorial Hospital, the Thai Red Cross Society (Chulalongkorn Hospital), in collaboration with the Departments of Hematology, Pulmonary and Critical Care Medicine, and Infectious diseases, held a press conference on “Thailand’s first successful treatment of systemic sclerosis patients with pulmonary fibrosis by stem cell transplantation“.

Released: 4-May-2021 8:00 AM EDT
New Clinical Practice Guideline on Community Acquired Pneumonia;
American Thoracic Society (ATS)

In its latest clinical practice guideline on community-acquired pneumonia the American Thoracic Society’s guidelines panel addresses the use of nucleic acid-based testing for non-influenza viral pathogens. The guideline was published online in the May 1 issue of the American Journal of Respiratory and Critical Care Medicine. An explainer video may be viewed here.

28-Apr-2021 7:05 AM EDT
Pulmonary Endarterectomy Achieves Excellent Results for Patients with Segmental Chronic Thromboembolic Pulmonary Hypertension
American Association for Thoracic Surgery (AATS)

Pulmonary Endarterectomy Achieves Excellent Results for Patients with Segmental Chronic Thromboembolic Pulmonary Hypertension

27-Apr-2021 6:30 PM EDT
Study Finds Similar Long-Term Outcomes for Mechanically-Ventilated COVID-19 Patients Treated With and Without ECMO
American Association for Thoracic Surgery (AATS)

A new study, presented today at the AATS 101st Annual Meeting, found that severely ill COVID-19 patients treated with ECMO did not suffer worse long-term outcomes than other mechanically-ventilated patients.

Released: 28-Apr-2021 12:45 PM EDT
A Patient Pioneer: Minimally Invasive Lung Transplantation
Cedars-Sinai

To anyone else, it’s just a walk around the block. But for Frank Coburn, 57, and his wife, it’s a miracle. A miracle that resulted from Coburn becoming the first Southern Californian—and possibly first in the U.S.—to receive a minimally invasive double lung transplant. The procedure was performed at the Smidt Heart Institute.

Released: 28-Apr-2021 9:00 AM EDT
Christmas Eve Coke Works Fire Followed by Asthma Exacerbations
Health Sciences at the University of Pittsburgh

Asthma exacerbations rose following a catastrophic Christmas Eve fire that destroyed pollution controls at the Clairton Coke Works – the largest such facility in the nation, a University of Pittsburgh Graduate School of Public Health analysis concludes.

Released: 27-Apr-2021 11:20 AM EDT
Virtual Lung Cancer Screenings Being Offered by Hackensack Meridian Health
Hackensack Meridian Health

Telehealth Visits Provide Early Detection, More Treatment Options and Better Chance of Survival

20-Apr-2021 9:00 AM EDT
Using Big Data to Save Babies
Federation of American Societies for Experimental Biology (FASEB)

Although bronchopulmonary dysplasia (BPD)—a chronic lung disease affecting newborns—is the most common complication of preterm birth, it remains difficult to diagnose and treat. Researchers from Fundación INFANT in Buenos Aires, Argentina, and The University of Oklahoma Health Sciences Center, hope to address these difficulties using machine learning to inform the clinical care of preemies with BPD.

20-Apr-2021 9:00 AM EDT
SARS-CoV-2 Spike Protein Alone May Cause Lung Damage
Federation of American Societies for Experimental Biology (FASEB)

Using a newly developed mouse model of acute lung injury, researchers found that exposure to the SARS-CoV-2 spike protein alone was enough to induce COVID-19-like symptoms including severe inflammation of the lungs.

20-Apr-2021 9:00 AM EDT
Capsaicin Analog Could Help Treatment-Resistant Lung Cancer
Federation of American Societies for Experimental Biology (FASEB)

A new study found that non-pungent synthetic analog of capsaicin — the compound that makes chili peppers hot — made small cell lung cancer cells more responsive to treatment. Small cell lung cancer is a very aggressive form of cancer with a low survival rate.



close
1.74329